Status:
Concluded without agreement
Manufacturer:
Galderma Canada Inc.
Indication:
Rosacea
Last updated May 23, 2018
Status:
Concluded with an LOI
Manufacturer:
Pfizer Canada ULC
Indication:
Gaucher disease
Last updated May 17, 2018
Status:
Concluded with an LOI
Manufacturer:
AstraZeneca Canada Inc.
Indication:
Ovarian Cancer, monotherapy for the maintenance treatment of female adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy
Last updated May 15, 2018
Status:
Negotiations were not pursued
Manufacturer:
Amgen Canada Inc.
Indication:
Left Sided Metastatic Colorectal Cancer
Last updated May 10, 2018
Status:
Concluded with an LOI
Manufacturer:
Bayer Inc.
Indication:
Conception Control
Last updated April 20, 2018
Status:
Concluded with an LOI
Manufacturer:
Shire Pharma Canada ULC
Indication:
Gaucher disease
Last updated April 16, 2018
Status:
Negotiations were not pursued
Manufacturer:
Biogen Canada Inc.
Indication:
Multiple Sclerosis, Relapsing
Last updated March 29, 2018
Status:
Concluded with an LOI
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Indication:
Non-Squamous Non-Small Cell Lung Cancer
Last updated March 20, 2018
Status:
Concluded with an LOI
Manufacturer:
Pendopharm, a division of Pharmascience Inc.
Indication:
Multiple Sclerosis, Relapsing-Remitting
Last updated March 1, 2018
Status:
Concluded with an LOI
Manufacturer:
Allergan Inc.
Indication:
Multiple Indications
Last updated February 28, 2018